Why are clinical trials struggling with diversity?
pharmaphorum
MAY 26, 2022
Despite policies, guidelines, and regulations to promote the diversification of clinical trial groups by the European Medicines Agency (EMA) and FDA, the inclusion of key demographic populations within clinical research continues to be less than proportionate to their representation in society. About the authors.
143 
Let's personalize your content